Literature DB >> 16996940

Prognostic implications of preoperative atrial fibrillation in patients undergoing aortic valve replacement: is there an argument for concomitant arrhythmia surgery?

Dumbor L Ngaage1, Hartzell V Schaff, Sunni A Barnes, Thoralf M Sundt, Charles J Mullany, Joseph A Dearani, Richard C Daly, Thomas A Orszulak.   

Abstract

BACKGROUND: The prognostic significance of preoperative atrial fibrillation (AF) at the time of aortic valve replacement is unknown, as is the potential role for concomitant arrhythmia surgery.
METHODS: We performed a cohort comparison of patients with preoperative AF (n = 129) and preoperative sinus rhythm (SR, n = 252) undergoing aortic valve surgery between 1993 and 2002; patients were matched for age, gender, and left ventricular ejection fraction. Follow-up (mean interval, 4.5 years) was 98% complete. Primary endpoints were late cardiac and all-cause mortality, as well as major adverse cardiac or cerebrovascular event.
RESULTS: Patients with preoperative AF presented with more severe congestive heart failure (p = 0.03) and more often had significant tricuspid regurgitation (p = 0.01) preoperatively. They also had worse late survival (risk ratio [RR] for death = 1.5, p = 0.03) with 1-, 5-, and 7-year survival rates substantially reduced at 94%, 87%, and 50%, respectively, for those in AF versus 98%, 90%, and 61% for patients in sinus rhythm preoperatively. Individuals in AF had a greater probability of subsequent rhythm-related intervention (RR = 4.7, p = 0.0002), and more frequently developed congestive heart failure (25% vs 10%, p = 0.005) and stroke (16% vs 5%, p = 0.005). By multivariable analysis, preoperative AF was an independent predictor of late adverse cardiac and cerebrovascular events, but not late death.
CONCLUSIONS: Performance of concomitant arrhythmia surgery in patients undergoing aortic valve surgery may reduce late morbidity; however, its potential impact on late mortality in this high-risk subset of patients remains unclear.

Entities:  

Mesh:

Year:  2006        PMID: 16996940     DOI: 10.1016/j.athoracsur.2006.04.004

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  18 in total

Review 1.  Management of Atrial Fibrillation in Patients Undergoing Coronary Artery Bypass Grafting: Review of the Literature.

Authors:  Ali J Khiabani; Taylan Adademir; Richard B Schuessler; Spencer J Melby; Marc R Moon; Ralph J Damiano
Journal:  Innovations (Phila)       Date:  2018 Nov/Dec

2.  A review of current surgical treatment of patients with atrial fibrillation.

Authors:  Zachary J Edgerton; James R Edgerton
Journal:  Proc (Bayl Univ Med Cent)       Date:  2012-07

3.  When is your surgeon good enough? When do you need a "referent surgeon"?

Authors:  Patrick M McCarthy
Journal:  Curr Cardiol Rep       Date:  2009-03       Impact factor: 2.931

Review 4.  2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design.

Authors:  Hugh Calkins; Karl Heinz Kuck; Riccardo Cappato; Josep Brugada; A John Camm; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; John DiMarco; James Edgerton; Kenneth Ellenbogen; Michael D Ezekowitz; David E Haines; Michel Haissaguerre; Gerhard Hindricks; Yoshito Iesaka; Warren Jackman; Jose Jalife; Pierre Jais; Jonathan Kalman; David Keane; Young-Hoon Kim; Paulus Kirchhof; George Klein; Hans Kottkamp; Koichiro Kumagai; Bruce D Lindsay; Moussa Mansour; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Douglas L Packer; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Vivek Reddy; Jeremy N Ruskin; Richard J Shemin; Hsuan-Ming Tsao; David Wilber
Journal:  J Interv Card Electrophysiol       Date:  2012-03       Impact factor: 1.900

5.  Electrophysiological study 6 months after Epicor™ high-intensity focused ultrasound atrial fibrillation ablation.

Authors:  Rodrigue Garcia; Frédéric Sacher; Pierre Oses; Nicolas Derval; Laurent Barandon; Arnaud Denis; Mélèze Hocini; Xavier Roques; Michel Haïssaguerre; Louis Labrousse; Pierre Jaïs
Journal:  J Interv Card Electrophysiol       Date:  2014-11-09       Impact factor: 1.900

6.  Effectiveness of Surgical Ablation in Patients With Atrial Fibrillation and Aortic Valve Disease.

Authors:  Matthew C Henn; Christopher P Lawrance; Laurie A Sinn; Jacob R Miller; Richard B Schuessler; Marc R Moon; Spencer J Melby; Hersh S Maniar; Ralph J Damiano
Journal:  Ann Thorac Surg       Date:  2015-07-22       Impact factor: 4.330

Review 7.  Clinical implications of conduction abnormalities and arrhythmias after transcatheter aortic valve implantation.

Authors:  Robert M A van der Boon; Patrick Houthuizen; Rutger-Jan Nuis; Nicolas M van Mieghem; Frits Prinzen; Peter P T de Jaegere
Journal:  Curr Cardiol Rep       Date:  2014-01       Impact factor: 2.931

8.  Ablation of atrial fibrillation with the Epicor system: a prospective observational trial to evaluate safety and efficacy and predictors of success.

Authors:  Simon Schopka; Christof Schmid; Andreas Keyser; Ariane Kortner; Julia Tafelmeier; Claudius Diez; Leopold Rupprecht; Michael Hilker
Journal:  J Cardiothorac Surg       Date:  2010-05-05       Impact factor: 1.637

9.  Preoperative atrial fibrillation is an independent risk factor for mid-term mortality after concomitant aortic valve replacement and coronary artery bypass graft surgery.

Authors:  Akshat Saxena; Diem Dinh; Jim Dimitriou; Christopher Reid; Julian Smith; Gilbert Shardey; Andrew Newcomb
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-01-03

10.  Performance of the Cox-maze IV procedure is associated with improved long-term survival in patients with atrial fibrillation undergoing cardiac surgery.

Authors:  Farah N Musharbash; Matthew R Schill; Laurie A Sinn; Richard B Schuessler; Hersh S Maniar; Marc R Moon; Spencer J Melby; Ralph J Damiano
Journal:  J Thorac Cardiovasc Surg       Date:  2017-09-27       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.